EP3521282
Kínasólínafleiður sem eru notaðar til að meðhöndla HIV
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.12.2015EP published:
25.8.2021EP application number:
18213309.0
EP translation filed:
22.9.2021Grant published:
15.10.2021EPO information:
European Patent Register
Max expiry date:
22.12.2035Expiry date:
22.12.2026Next due date:
31.12.2026
Title:
QUINAZOLINE DERIVATIVES USED TO TREAT HIV
Timeline
Today
23.12.2015EP application
25.8.2021EP Publication
22.9.2021Translation submitted
15.10.2021Registration published
22.12.2026Expires
Owner
Name:
Gilead Sciences, Inc.Address:
333 Lakeside Drive, Foster City, CA 94404, US
Name:
Institute of Organic Chemistry and Biochemistry AS CR, V.V.I.Address:
Flemingovo nam. 2, 16610 Praha 6, CZ
Inventor
Name:
JANSA, PetrAddress:
Foster City, CA 94404, US
Name:
SIMON, PetrAddress:
166 10 Praha 6, CZ
Name:
LANSDON, EricAddress:
Foster City, CA 94404, US
Name:
HU, Yunfeng EricAddress:
Foster City, CA 94404, US
Name:
BASZCZYNSKI, OndrejAddress:
166 10 Praha 6, CZ
Name:
DEJMEK, MilanAddress:
166 10 Praha 6, CZ
Name:
MACKMAN, Richard, L.Address:
Foster City, CA 94404, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201462096748 PDate:
24.12.2014Country:
US
Classification
Categories:
C07D 401/12, C07D 239/94, A61K 31/517, A61P 31/18
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 8.11.2021
Expires: 22.12.2022
Payer: Árnason Faktor ehf.
Number: 8
Paid: 11.11.2022
Expires: 22.12.2023
Payer: Árnason Faktor ehf.
Number: 9
Paid: 11.12.2023
Expires: 22.12.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 27.12.2024
Expires: 22.12.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 17.12.2025
Expires: 22.12.2026
Payer: Árnason Faktor ehf.